Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
ncarol.com/10321454

FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical announces that SafeBreak® Vascular has been added to Alliant Purchasing's contract portfolio, expanding access to the breakaway IV technology across Alliant's extensive healthcare network. Alliant represents more than 280 hospitals and over 68,000 non-acute healthcare facilities across all 50 states. This agreement enables Alliant members to procure SafeBreak Vascular through streamlined contracting, supporting supply chain efficiency while bringing clinically proven IV complication reduction to a broader patient population.

SafeBreak Vascular is a breakaway device for IV lines clinically proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

More on ncarol.com

• $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
• ASI Hosts 2026 Executive Business Summit for Global Partner Community
• US Interest Rate Pivot: Hedge Funds Leverage Tickeron AI for 177% Annualized Return
• Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
• New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory

"Joining the Alliant portfolio strengthens our ability to serve healthcare systems at scale," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "Group purchasing organizations(GPO) like Alliant play a critical role in helping hospitals evaluate and adopt innovative technologies while optimizing their supply chain operations. This contract provides a clear procurement pathway for Alliant members and supports our commercial growth as we continue expanding SafeBreak's presence in hospitals nationwide."

"The addition of SafeBreak to the Alliant GPO contract is a significant step forward in our mission to remove the pains associated with IV lines," said Vance Clement, CEO of Lineus Medical. "This agreement means that thousands of healthcare facilities across the country now have simplified access to SafeBreak."

The Alliant contract adds to Lineus Medical's growing presence in the group purchasing space, providing healthcare facilities with accessible options for adopting SafeBreak Vascular as part of their IV protocols.

More on ncarol.com

• Craigory Dunn & Dre Barracks Release Gospel-Soul Collaboration The Soul Renaissance
• Why Screen-Fatigued Parents are Choosing the Human Bridge
• Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
• Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
• Luxur Tequila Introduces a New Standard of Luxury Spirits with Customizable Bottles & Visionary Lea

About Lineus Medical:

Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

About Alliant Purchasing:

Alliant Purchasing is a creative, value-focused, and progressive healthcare improvement partner that has been serving providers nationwide for over 35 years. With a commitment to operational and financial innovation, Alliant empowers members to navigate today's healthcare landscape through simplified supply chain strategies and impactful margin improvement opportunities. Leveraging more than $84 billion in buying power, Alliant supports over 280 hospitals and 68,000 provider locations. Learn more at www.alliantpurchasing.com.

References:

1. Data on file.